In 1993 they got into contract drug manufacturing by forming the subsidiary called King.
Since last fall the Chinese regulator has revoked 350 drug manufacturing licenses and vowed to tighten inspection of pharmaceuticals, according to accounts.
It would be one thing if a particular drug has been antiquated by new medicines that provide a better result, thereby mooting the reason for a drug company to continue manufacturing a drug that is no longer the state of the art.
The Executive Order also requires FDA to expand its current efforts to expedite review of new manufacturing sites, drug suppliers, and manufacturing changes to help prevent shortages.
Under an agreement signed in 2000, German firm Bayer is responsible for the third stage of trials and marketing of the drug while PPL takes on manufacturing the drug.
Clark, who has expertise in drug marketing and manufacturing, will probably have to lean very heavily on Merck's research chief, Peter Kim , to find new drugs to fill the company's ailing pipeline.
After Brazil agreed to recognise their patents, in 1996, many foreign drug firms set up manufacturing plants.
"The professional assurance for sterility is orders of magnitude less than the federal standards for sterility, " said Sarah Sellers, a former FDA compliance official who now consults for drug makers on safe manufacturing.
Yet, despite this fantastic success rate, kids are now in danger of facing this disease without this life saving drug all because manufacturing the medicine is no longer as profitable for the pharmaceutical companies as it once was.
The U.S. Food and Drug Administration last month inspected a company manufacturing plant in Minnesota and found no problems that could have caused the defect.
He became embroiled in discussions with the U.S. Food and Drug Administration over problems with Schering's manufacturing procedures.
India's patent law allows authorities to order holders of drug patents to license their products for local manufacturing if they are priced beyond the reach of patients.
To try to extend the lives of a pill, a company may patent it multiple times, protecting not only a chemical compound but also manufacturing methods or uses for the drug.
Much attention has been given to manufacturing problems at plants run by generic drug makers.
But big drug firms are the ones with the money and manufacturing technology to get into this business easily.
Despite its wobbly start at selling branded drugs, Anexia gave King a taste for bigger gross margins: 75% for a brand drug, versus 20% or less for contract manufacturing.
But a Consumer Reports analysis found that the FDA was as likely to warn about manufacturing issues at a brand-name drug factory as a generic one, Dr. Santa says.
The drug has benefited partly from a shortage of generic drug rival Leucovirin, notes Yang, caused mainly by manufacturing delays.
FORBES: Why This Tiny But Profitable Biotech May Be Gobbled Up By Big Pharma
Idec's manufacturing capabilities have been turned toward making the drug.
Bernstein analysts Tim Anderson and Ronny Gal are out this morning with a note to investors suggesting that generic Lipitor could be delayed because of manufacturing problems at Ranbaxy, the first generic drug maker to file with the Food and Drug Administration and the company with whom Pfizer settled.
Under the law, generic manufacturers got a sort of junior patent if they were the first to challenge, a 180-day exclusive period to sell competing versions of a drug after they won their challenge and got set up for manufacturing.
Although several drug companies have agreed to supply the drugs to African countries at manufacturing cost (the price in the rich world factors in development costs as well), that is still beyond the purse of any but the middle classes in Africa.
ECONOMIST: Cutting their drug doses may benefit AIDS patients
Unfortunately, federal regulators at the Food and Drug Administration have said they won't approve Clarinex until Schering resolves manufacturing problems at plants in New Jersey and Puerto Rico.
Not only would Mylan have to wait longer to launch its generic, the longer wait would mean that other generic drug companies would have time to jump the regulatory, legal, and manufacturing hurdles needed to market their own copies.
Dennis Harp, a biotechnology analyst at Deutsche Bank, sees another reason for the increase: Amgen, he says, seems to finally be working its way through the manufacturing problems that have constrained the supply of its rheumatoid arthritis drug Enbrel.
Mylan had sued the agency in March, claiming that it and other generic-drug makers should be allowed to enter the market as early as June because of manufacturing violations at two Ranbaxy factories in India.
These were that the trial was run correctly, doses of the drug were given as they were supposed to have been, and there was no contamination during manufacturing.
The new margins will be based on each drug's production costs, ignoring research spending and other shared overheads, which far exceed the manufacturing outlay for new medicines.
Back in February, regulators at the Food and Drug Administration said they wouldn't give Schering the go-ahead to market the antihistamine until it cleared up manufacturing problems with some of its plants.
应用推荐